Optimization of conditions for ex vivo expansion of CD34+ cells from patients with stage IV breast cancer.
暂无分享,去创建一个
L. Norton | M. Moore | F. Shapiro | G. Raptis | T. Yao | L. Reich | Lilian Reich | Larry Norton | George Raptis | Fred Shapiro | Tzy-Jyun | Moore
[1] C. Hudis,et al. Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] C. Rinaldo,et al. A phase 1 study of adoptive transfer of autologous CD8+ T lymphocytes in patients with acquired immunodeficiency syndrome (AIDS)-related complex or AIDS. , 1993, Blood.
[3] G. Bastert,et al. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] L. Kanz,et al. Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin. , 1992, Blood.
[5] C. Verfaillie,et al. Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. , 1992, Blood.
[6] G. Bonadonna,et al. Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] P. Lansdorp,et al. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. , 1991, Blood.
[8] R. Mick,et al. High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] R. Bast,et al. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] T. Shea,et al. High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] M. Moore,et al. Ex vivo expansion of CD34+ hematopoietic progenitors. , 1994, Progress in clinical and biological research.
[12] E. Shpall,et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] S. Emerson,et al. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. , 1993, Blood.
[14] P. Mauch,et al. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. , 1993, Experimental hematology.
[15] M. Moore,et al. Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential. , 1993, Blood.
[16] L. Norton,et al. The Norton-Simon hypothesis revisited. , 1986, Cancer treatment reports.